[1]
T. Sowjanya, K. Dhanasri, D. Kedhareswari, C. Vani, B. Keerthi, and B. VaniHepsiba, “Heterocyclic Tyrosine Kinase Inhibitors: Structural Insights and Medicinal Chemistry Strategies in Cancer, Immune-Mediated Disorders and Myeloproliferative Neoplasms”, Adolescência e Saúde, pp. 2011–2020, Oct. 2026.